Literature DB >> 27521419

Extracellular matrix fibronectin mediates an endothelial cell response to shear stress via the heparin-binding, matricryptic RWRPK sequence of FNIII1H.

William Okech1, Keren M Abberton2, Julia M Kuebel2, Denise C Hocking3, Ingrid H Sarelius4.   

Abstract

Endothelial cells (EC) respond to mechanical forces such as shear stress in a variety of ways, one of which is cytoskeletal realignment in the direction of flow. Our earlier studies implicated the extracellular matrix protein fibronectin in mechanosensory signaling to ECs in intact arterioles, via a signaling pathway dependent on the heparin-binding region of the first type III repeat of fibrillar fibronectin (FNIII1H). Here we test the hypothesis that FNIII1H is required for EC stress fiber realignment under flow. Human umbilical vein ECs (HUVECs) exposed to defined flow conditions were used as a well-characterized model of this stress fiber alignment response. Our results directly implicate FNIII1H in realignment of stress fibers in HUVECs and, importantly, show that the matricryptic heparin-binding RWRPK sequence located in FNIII1 is required for the response. Furthermore, we show that flow-mediated stress fiber realignment in ECs adhered via α5β1-integrin-specific ligands does not occur in the absence of FHIII1H, whereas, in contrast, αvβ3-integrin-mediated stress fiber realignment under flow does not require FNIII1H. Our findings thus indicate that there are two separate mechanosignaling pathways mediating the alignment of stress fibers after exposure of ECs to flow, one dependent on αvβ3-integrins and one dependent on FNIII1H. This study strongly supports the conclusion that the RWRPK region of FNIII1H may have broad capability as a mechanosensory signaling site.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  extracellular matrix signaling; fluid shear stress-dependent endothelial responses; mechanotransduction in endothelium

Mesh:

Substances:

Year:  2016        PMID: 27521419      PMCID: PMC5114463          DOI: 10.1152/ajpheart.00126.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  34 in total

Review 1.  Local control of blood flow during active hyperaemia: what kinds of integration are important?

Authors:  Coral L Murrant; Ingrid H Sarelius
Journal:  J Physiol       Date:  2015-09-29       Impact factor: 5.182

2.  Extracellular matrix fibronectin mechanically couples skeletal muscle contraction with local vasodilation.

Authors:  Denise C Hocking; Patricia A Titus; Ronen Sumagin; Ingrid H Sarelius
Journal:  Circ Res       Date:  2007-11-21       Impact factor: 17.367

3.  Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression.

Authors:  Eleni Tzima; Miguel Angel Del Pozo; William B Kiosses; Samih A Mohamed; Song Li; Shu Chien; Martin Alexander Schwartz
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

4.  Recombinant fibronectin matrix mimetics specify integrin adhesion and extracellular matrix assembly.

Authors:  Daniel C Roy; Denise C Hocking
Journal:  Tissue Eng Part A       Date:  2012-11-01       Impact factor: 3.845

5.  Fibronectin matrix turnover occurs through a caveolin-1-dependent process.

Authors:  Jane Sottile; Jennifer Chandler
Journal:  Mol Biol Cell       Date:  2004-11-24       Impact factor: 4.138

6.  Changes in organization and composition of the extracellular matrix underlying cultured endothelial cells exposed to laminar steady shear stress.

Authors:  O Thoumine; R M Nerem; P R Girard
Journal:  Lab Invest       Date:  1995-10       Impact factor: 5.662

7.  Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow.

Authors:  Peter L Voyvodic; Daniel Min; Robert Liu; Evan Williams; Vipul Chitalia; Andrew K Dunn; Aaron B Baker
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

8.  Extracellular matrix fibronectin initiates endothelium-dependent arteriolar dilatation via the heparin-binding, matricryptic RWRPK sequence of the first type III repeat of fibrillar fibronectin.

Authors:  Ingrid H Sarelius; Patricia A Titus; Nir Maimon; William Okech; Susan J Wilke-Mounts; James R Brennan; Denise C Hocking
Journal:  J Physiol       Date:  2016-01-15       Impact factor: 5.182

9.  Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands.

Authors:  S Jalali; M A del Pozo ; K Chen; H Miao; Y Li; M A Schwartz; J Y Shyy; S Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

10.  A cryptic fragment from fibronectin's III1 module localizes to lipid rafts and stimulates cell growth and contractility.

Authors:  Denise C Hocking; Katherine Kowalski
Journal:  J Cell Biol       Date:  2002-07-08       Impact factor: 10.539

View more
  4 in total

1.  Endothelial Glycocalyx Layer Properties and Its Ability to Limit Leukocyte Adhesion.

Authors:  Luis F Delgadillo; Graham A Marsh; Richard E Waugh
Journal:  Biophys J       Date:  2020-02-15       Impact factor: 4.033

Review 2.  Thrombospondins: A Role in Cardiovascular Disease.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2017-07-17       Impact factor: 5.923

Review 3.  Brain vascular heterogeneity: implications for disease pathogenesis and design of in vitro blood-brain barrier models.

Authors:  Midrelle E Noumbissi; Bianca Galasso; Monique F Stins
Journal:  Fluids Barriers CNS       Date:  2018-04-23

4.  A Matricryptic Conformation of the Integrin-Binding Domain of Fibronectin Regulates Platelet-Derived Growth Factor-Induced Intracellular Calcium Release.

Authors:  Christopher S Farrar; Geoffrey T Rouin; Benjamin L Miller; Carol H Raeman; Nancie A Mooney; Denise C Hocking
Journal:  Cells       Date:  2019-10-30       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.